{"id":73310,"date":"2025-12-30T10:39:17","date_gmt":"2025-12-30T01:39:17","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/thyroid-gland-disorders-treatment-market-mordor\/"},"modified":"2026-09-29T18:23:36","modified_gmt":"2026-09-29T09:23:36","slug":"thyroid-gland-disorders-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/thyroid-gland-disorders-treatment-market-mordor\/","title":{"rendered":"\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834 \u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u30c8\u30ec\u30f3\u30c9\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/thyroid-gland-disorders-treatment-market_1676628509374_Thyroid_Disorders_Treatment_Market_key_players-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/thyroid-gland-disorders-treatment-market-size-image-1735455354066.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u30e8\u30a6\u7d20\u6b20\u4e4f\u75c7\u60a3\u8005\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u7532\u72b6\u817a\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3068\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u653f\u5e9c\u306e\u53d6\u308a\u7d44\u307f\u306e\u5897\u52a0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u6cbb\u7642\u8cbb\u306e\u9ad8\u9a30<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u4ee3\u66ff\u6cbb\u7642\u306e\u5229\u7528\u53ef\u80fd\u6027<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\uff08\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 &#8211; USD\u767e\u4e07\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u75be\u60a3\u306e\u7a2e\u985e\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u305d\u306e\u4ed6\u306e\u75be\u60a3<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u6295\u4e0e\u7d4c\u8def\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u7d4c\u53e3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u975e\u7d4c\u53e3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u85ac\u5264\u30af\u30e9\u30b9\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u30c1\u30aa\u30a2\u30df\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u30a4\u30aa\u30f3\u963b\u5bb3\u5264<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u30db\u30eb\u30e2\u30f3\u653e\u51fa\u963b\u5bb3\u5264<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 \u305d\u306e\u4ed6\u306e\u85ac\u5264\u30af\u30e9\u30b9<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5378\u58f2\u6d41\u901a<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u5c0f\u58f2\u5e97<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u30d7\u30ed\u30d5\u30a3\u30fc\u30eb<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 Abbvie Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 Amgen Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 GSK Plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 Merck KGaA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 Viatris Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 Pfizer Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 Takeda Pharmaceutical Company Limited<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 Elexis Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 IBSA Pharma (IBSA Group)<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\u5229\u7528\u53ef\u80fd\u72b6\u6cc1\u306b\u3088\u308b<\/div>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306e\u5bfe\u8c61 &#8211; \u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u300c\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\uff1a\u6210\u9577\u30c8\u30ec\u30f3\u30c9\u30682025\u5e74\uff5e2030\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u300d\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u4e16\u754c\u306e\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b3.5%\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u672c\u5e02\u5834\u306f\u30012019\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u671f\u9593\u3092\u8abf\u67fb\u5bfe\u8c61\u3068\u3057\u30012024\u5e74\u3092\u57fa\u6e96\u5e74\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306f\u3001\u75be\u60a3\u306e\u7a2e\u985e\uff08\u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u3001\u305d\u306e\u4ed6\u306e\u75be\u60a3\uff09\u3001\u6295\u4e0e\u7d4c\u8def\uff08\u7d4c\u53e3\u3001\u975e\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def\uff09\u3001\u85ac\u5264\u30af\u30e9\u30b9\uff08\u30c1\u30aa\u30a2\u30df\u30c9\u7cfb\u85ac\u5264\u3001\u30a4\u30aa\u30f3\u963b\u5bb3\u5264\u3001\u30db\u30eb\u30e2\u30f3\u653e\u51fa\u963b\u5bb3\u5264\u3001\u305d\u306e\u4ed6\u306e\u85ac\u5264\u30af\u30e9\u30b9\uff09\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\uff08\u5378\u58f2\u6d41\u901a\u3001\u5c0f\u58f2\u5e97\u306a\u3069\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u306b\u3088\u3063\u3066\u7d30\u5206\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306f\u3001\u7532\u72b6\u817a\u75be\u60a3\u3092\u6301\u3064\u4eba\u3005\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3057\u307e\u3057\u305f\u30022022\u5e742\u6708\u306eJournal of the International Medicine and Research\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001SARS-CoV-2\u30a6\u30a4\u30eb\u30b9\u306f\u7532\u72b6\u817a\u304a\u3088\u3073\u8996\u5e8a\u4e0b\u90e8-\u4e0b\u5782\u4f53-\u7532\u72b6\u817a\uff08HPT\uff09\u8ef8\u5168\u4f53\u306b\u7279\u5b9a\u306e\u6a19\u7684\u3092\u6301\u3064\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002\u30d0\u30bb\u30c9\u30a6\u75c5\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u6b63\u5e38\u75c7\u5019\u7fa4\u3001\u6a4b\u672c\u75c5\u3001\u4e9c\u6025\u6027\u7532\u72b6\u817a\u708e\u3068\u3044\u3063\u305f\u591a\u304f\u306e\u7532\u72b6\u817a\u75be\u60a3\u304cCOVID-19\u306e\u5f8c\u907a\u75c7\u3068\u3057\u3066\u7279\u5b9a\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u75c5\u56e0\u304cSARS-CoV-2\u30a6\u30a4\u30eb\u30b9\u3068\u95a2\u9023\u4ed8\u3051\u3089\u308c\u307e\u3057\u305f\u3002\u307e\u305f\u30012022\u5e7410\u6708\u306eDiabetes &#038; Metabolic Syndrome\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u3067\u306f\u3001\u7532\u72b6\u817a\u7570\u5e38\u304cCOVID-19\u306e\u8907\u5408\u7684\u306a\u4e0d\u826f\u8ee2\u5e30\u306e\u30ea\u30b9\u30af\u3092\u9ad8\u3081\u3001\u60a3\u8005\u306e\u5e74\u9f62\u306b\u5f71\u97ff\u3055\u308c\u308b\u3053\u3068\u304c\u6307\u6458\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u671f\u9593\u4e2d\u306b\u7532\u72b6\u817a\u6cbb\u7642\u306e\u9700\u8981\u304c\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u5e02\u5834\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u3001\u5b89\u5b9a\u3057\u305f\u6210\u9577\u7387\u3092\u8a18\u9332\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306e\u4e3b\u306a\u63a8\u9032\u8981\u56e0\u306f\u3001\u30e8\u30a6\u7d20\u6b20\u4e4f\u75c7\u60a3\u8005\u306e\u5897\u52a0\u3067\u3059\u30022022\u5e742\u6708\u306b\u4fdd\u5065\u5bb6\u65cf\u798f\u7949\u7701\u304c\u767a\u8868\u3057\u305f\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001\u30a4\u30f3\u30c9\u306b\u304a\u3051\u308b\u81ea\u5df1\u7533\u544a\u306b\u3088\u308b\u7532\u72b6\u817a\u816b\u307e\u305f\u306f\u7532\u72b6\u817a\u75be\u60a3\u306e\u6709\u75c5\u7387\u306f\u3001\u524d\u5e74\u306b2.9%\u306b\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306b\u3001\u7532\u72b6\u817a\u75be\u60a3\u306e\u5897\u52a0\u304c\u5e02\u5834\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3055\u3089\u306b\u30012022\u5e748\u6708\u306eNational Center of Biotechnology Information\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001\u30e8\u30a6\u7d20\u306f\u6700\u3082\u4e00\u822c\u7684\u306a\u6804\u990a\u6b20\u4e4f\u75c7\u306e\u4e00\u3064\u3067\u3042\u308a\u3001\u524d\u5e74\u306b\u306f\u4e16\u754c\u306e\u4eba\u53e3\u306e35\uff5e45%\u304c\u5f71\u97ff\u3092\u53d7\u3051\u305f\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30e8\u30a6\u7d20\u6b20\u4e4f\u75c7\u306f\u7532\u72b6\u817a\u816b\u306e\u6700\u3082\u4e00\u822c\u7684\u306a\u539f\u56e0\u3067\u3042\u308a\u3001\u4e16\u754c\u4e2d\u306722\u5104\u4eba\u304c\u7f79\u60a3\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30e8\u30a6\u7d20\u6b20\u4e4f\u75c7\u306e\u5927\u304d\u306a\u8ca0\u62c5\u304c\u7532\u72b6\u817a\u75be\u60a3\u306b\u3064\u306a\u304c\u308a\u3001\u5e02\u5834\u6210\u9577\u3092\u52a0\u901f\u3055\u305b\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306b\u3088\u308b\u627f\u8a8d\u3001\u767a\u58f2\u3001\u63d0\u643a\u306e\u5897\u52a0\u3082\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u898b\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e7411\u6708\u306b\u306f\u3001\u30b9\u30a4\u30b9\u306e\u533b\u7642\u6280\u8853\u4f01\u696dBloom Diagnostics\u304c\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7\u306e\u691c\u51fa\u3092\u652f\u63f4\u3059\u308bBloom Thyroid Test\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30c6\u30b9\u30c8\u306f\u8a8d\u8a3c\u6a5f\u95a2\u304b\u3089\u627f\u8a8d\u8a3c\u660e\u66f8\u3092\u53d6\u5f97\u3057\u3001\u30e6\u30fc\u30b6\u30fc\u304c\u81ea\u5b85\u3067\u691c\u67fb\u3092\u5b9f\u65bd\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002<br \/>\n\u3053\u308c\u3089\u306e\u8981\u56e0\u3001\u3059\u306a\u308f\u3061\u7532\u72b6\u817a\u75be\u60a3\u306e\u5927\u304d\u306a\u8ca0\u62c5\u3068\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306b\u3088\u308b\u88fd\u54c1\u627f\u8a8d\u304a\u3088\u3073\u767a\u58f2\u306e\u5897\u52a0\u306b\u3088\u308a\u3001\u8abf\u67fb\u5bfe\u8c61\u5e02\u5834\u306f\u5206\u6790\u671f\u9593\u4e2d\u306b\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3057\u304b\u3057\u306a\u304c\u3089\u3001\u6cbb\u7642\u8cbb\u306e\u9ad8\u9a30\u3084\u4ee3\u66ff\u6cbb\u7642\u6cd5\u306e\u5b58\u5728\u304c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u75be\u60a3\u306e\u7a2e\u985e\u5225\u3067\u306f\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5927\u304d\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u4e16\u754c\u7684\u306b\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u304a\u3088\u3073\u7532\u72b6\u817a\u304c\u3093\u306e\u8ca0\u62c5\u304c\u5927\u304d\u3044\u3053\u3068\u306b\u8d77\u56e0\u3057\u307e\u3059\u30022022\u5e747\u6708\u306b\u66f4\u65b0\u3055\u308c\u305fStatpearls\u306e\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001\u6f5c\u5728\u6027\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u306f65\u6b73\u4ee5\u4e0a\u306e\u5973\u6027\u306b\u591a\u304f\u898b\u3089\u308c\u3001\u9855\u6027\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u306e\u767a\u751f\u7387\u306f\u5973\u60271000\u4eba\u3042\u305f\u308a0.4\u4eba\u3001\u7537\u60271000\u4eba\u3042\u305f\u308a0.1\u4eba\u3067\u3042\u308a\u3001\u5e74\u9f62\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3059\u3002\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u306e\u5927\u304d\u306a\u8ca0\u62c5\u306f\u3001\u305d\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u6a5f\u4f1a\u3092\u751f\u307f\u51fa\u3057\u3001\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u3055\u3089\u306b\u3001\u4e16\u754c\u7684\u306a\u7532\u72b6\u817a\u304c\u3093\u306e\u5927\u304d\u306a\u8ca0\u62c5\u3082\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u306e\u9ad8\u3044\u767a\u751f\u7387\u3068\u95a2\u9023\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u7c73\u56fd\u304c\u3093\u5354\u4f1a2023\u5e74\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u30012023\u5e74\u306b\u306f\u7c73\u56fd\u3067\u63a8\u5b9a43,700\u4ef6\u306e\u65b0\u898f\u7532\u72b6\u817a\u304c\u3093\u304c\u8a3a\u65ad\u3055\u308c\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001Cancer Australia 2022\u5e74\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3067\u306f\u4eca\u5e74\u63a8\u5b9a3,981\u4ef6\u306e\u65b0\u898f\u7532\u72b6\u817a\u304c\u3093\u304c\u8a3a\u65ad\u3055\u308c\u300185\u6b73\u307e\u3067\u306b\u7532\u72b6\u817a\u304c\u3093\u3068\u8a3a\u65ad\u3055\u308c\u308b\u30ea\u30b9\u30af\u306f80\u4eba\u306b1\u4eba\uff081.3%\uff09\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u7532\u72b6\u817a\u304c\u3093\u75c7\u4f8b\u306e\u5927\u304d\u306a\u8ca0\u62c5\u306f\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u6cbb\u7642\u306e\u9700\u8981\u3092\u751f\u307f\u51fa\u3057\u3001\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5e02\u5834\u3092\u652f\u914d\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u7532\u72b6\u817a\u75be\u60a3\u306e\u9ad8\u3044\u767a\u751f\u7387\u3001\u88fd\u54c1\u306e\u767a\u58f2\u3068\u627f\u8a8d\u3001\u304a\u3088\u3073\u3053\u306e\u5730\u57df\u306b\u304a\u3051\u308b\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306e\u96c6\u4e2d\u5ea6\u304c\u9ad8\u3044\u3053\u3068\u306b\u3088\u308b\u3082\u306e\u3067\u3059\u3002\u7532\u72b6\u817a\u304c\u3093\u306e\u5927\u304d\u306a\u8ca0\u62c5\u3068\u610f\u8b58\u306e\u9ad8\u307e\u308a\u304c\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u898b\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u30ab\u30ca\u30c0\u304c\u3093\u5354\u4f1a2022\u5e74\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u30012022\u5e74\u306b\u306f6,700\u4eba\u306e\u30ab\u30ca\u30c0\u4eba\u304c\u7532\u72b6\u817a\u304c\u3093\u3068\u8a3a\u65ad\u3055\u308c\u308b\u3068\u63a8\u5b9a\u3055\u308c\u307e\u3057\u305f\u3002\u307e\u305f\u30012023\u5e741\u6708\u306b\u306f\u3001\u7532\u72b6\u817a\u95a2\u9023\u75be\u60a3\u304a\u3088\u3073\u7532\u72b6\u817a\u304c\u3093\u306b\u5bfe\u3059\u308b\u610f\u8b58\u3092\u9ad8\u3081\u308b\u305f\u3081\u306b\u300c\u7532\u72b6\u817a\u5553\u767a\u6708\u9593\u300d\u304c\u4e16\u754c\u4e2d\u3067\u5b9f\u65bd\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306a\u53d6\u308a\u7d44\u307f\u306f\u65e9\u671f\u767a\u898b\u3068\u6cbb\u7642\u3092\u4fc3\u9032\u3057\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u52a0\u3048\u3066\u3001\u5e02\u5834\u53c2\u5165\u4f01\u696d\u306b\u3088\u308b\u627f\u8a8d\u3001\u88fd\u54c1\u767a\u58f2\u3001\u63d0\u643a\u306e\u5897\u52a0\u3082\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u898b\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e749\u6708\u306b\u306f\u3001Exelixis Inc.\u304c\u3001\u4ee5\u524d\u306e\u8840\u7ba1\u5185\u76ae\u5897\u6b96\u56e0\u5b50\u53d7\u5bb9\u4f53\uff08VEGFR\uff09\u6a19\u7684\u7642\u6cd5\u5f8c\u306b\u9032\u884c\u3057\u3001\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u4e0d\u5fdc\u6027\u307e\u305f\u306f\u4e0d\u9069\u683c\u306a\u5c40\u6240\u9032\u884c\u6027\u307e\u305f\u306f\u8ee2\u79fb\u6027\u5206\u5316\u578b\u7532\u72b6\u817a\u304c\u3093\uff08DTC\uff09\u306e\u6210\u4eba\u304a\u3088\u3073\u5c0f\u5150\u60a3\u8005\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3001CABOMETYX\uff08\u30ab\u30dc\u30b6\u30f3\u30c1\u30cb\u30d6\uff09\u306e\u7c73\u56fdFDA\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u7532\u72b6\u817a\u75be\u60a3\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u306a\u88fd\u54c1\u306e\u767a\u58f2\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u7af6\u4e89\u304c\u3042\u308a\u3001\u4e3b\u306b\u30b0\u30ed\u30fc\u30d0\u30eb\u4f01\u696d\u3067\u69cb\u6210\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u6cbb\u7642\u6cd5\u306e\u9769\u65b0\u304c\u9032\u3080\u3053\u3068\u3067\u3001\u5c06\u6765\u7684\u306b\u306f\u3044\u304f\u3064\u304b\u306e\u4e2d\u5c0f\u4f01\u696d\u304c\u5e02\u5834\u306b\u53c2\u5165\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u308b\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Abbvie Inc.\u3001Merck KGaA\u3001Viatris Inc.\u3001Pfizer Inc.\u3001Exelixis Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411\u3068\u3057\u3066\u306f\u3001\u4ee5\u4e0b\u306e\u70b9\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<br \/>\n*   2022\u5e7411\u6708\uff1a\u7c73\u56fd\u3092\u62e0\u70b9\u3068\u3059\u308bZydus Lifesciences\u306e\u5b50\u4f1a\u793e\u304c\u3001\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u6b20\u4e4f\u75c7\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u30ec\u30dc\u30c1\u30ed\u30ad\u30b7\u30f3\u30ca\u30c8\u30ea\u30a6\u30e0\u6ce8\u5c04\u5264\u306e\u7c73\u56fdFDA\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2022\u5e745\u6708\uff1a\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306f\u3001\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u30fb\u30a2\u30f3\u30c9\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc\u306e\u65b0\u3057\u3044\u90311\u56de\u6295\u4e0e\u306eGIP\uff08\u30b0\u30eb\u30b3\u30fc\u30b9\u4f9d\u5b58\u6027\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u523a\u6fc0\u30dd\u30ea\u30da\u30d7\u30c1\u30c9\uff09\u304a\u3088\u3073GLP-1\uff08\u30b0\u30eb\u30ab\u30b4\u30f3\u69d8\u30da\u30d7\u30c1\u30c9-1\uff09\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u3067\u3042\u308bMounjaro\uff08\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\uff09\u6ce8\u5c04\u5264\u3092\u3001\u98df\u4e8b\u7642\u6cd5\u3068\u904b\u52d5\u306e\u88dc\u52a9\u3068\u3057\u30662\u578b\u7cd6\u5c3f\u75c5\u6210\u4eba\u60a3\u8005\u306e\u8840\u7cd6\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u6539\u5584\u306e\u305f\u3081\u306b\u627f\u8a8d\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u8981\u56e0\u304b\u3089\u3001\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306f\u4eca\u5f8c\u3082\u7740\u5b9f\u306a\u6210\u9577\u3092\u7d9a\u3051\u308b\u3068\u898b\u8fbc\u307e\u308c\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u7532\u72b6\u817a\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u7532\u72b6\u817a\u75be\u60a3\u3068\u306f\u3001\u7532\u72b6\u817a\u304c\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u3092\u904e\u5270\u307e\u305f\u306f\u904e\u5c11\u306b\u751f\u6210\u3059\u308b\u72b6\u614b\u3092\u6307\u3057\u307e\u3059\u3002\u672c\u8abf\u67fb\u3067\u306f\u3001\u5e02\u5834\u306e\u4eee\u5b9a\u3068\u5b9a\u7fa9\u3001\u8abf\u67fb\u7bc4\u56f2\u304c\u660e\u78ba\u306b\u3055\u308c\u3066\u304a\u308a\u3001\u8a73\u7d30\u306a\u8abf\u67fb\u65b9\u6cd5\u8ad6\u306b\u57fa\u3065\u3044\u3066\u5206\u6790\u304c\u5b9f\u65bd\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc\u3067\u306f\u3001\u5e02\u5834\u306e\u4e3b\u8981\u306a\u6d1e\u5bdf\u304c\u307e\u3068\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u52d5\u5411\u3068\u3057\u3066\u306f\u3001\u307e\u305a\u5e02\u5834\u6982\u8981\u304c\u793a\u3055\u308c\u3001\u305d\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u4e3b\u8981\u56e0\u304c\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001\u30e8\u30a6\u7d20\u6b20\u4e4f\u75c7\u3092\u62b1\u3048\u308b\u60a3\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3001\u304a\u3088\u3073\u7532\u72b6\u817a\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3068\u6cbb\u7642\u306b\u95a2\u3059\u308b\u653f\u5e9c\u306e\u53d6\u308a\u7d44\u307f\u306e\u5f37\u5316\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001\u6cbb\u7642\u8cbb\u306e\u9ad8\u9a30\u3084\u4ee3\u66ff\u6cbb\u7642\u6cd5\u306e\u5229\u7528\u53ef\u80fd\u6027\u304c\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u306b\u306f\u3001\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u88fd\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3063\u305f\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u304c\u7528\u3044\u3089\u308c\u3001\u5e02\u5834\u306e\u69cb\u9020\u3068\u7af6\u4e89\u5ea6\u5408\u3044\u304c\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306f\u3001\u305d\u306e\u4fa1\u5024\uff08USD\u767e\u4e07\uff09\u306b\u57fa\u3065\u3044\u3066\u4ee5\u4e0b\u306e\u4e3b\u8981\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n1.  \u75be\u60a3\u306e\u7a2e\u985e\u5225: \u7532\u72b6\u817a\u6a5f\u80fd\u4f4e\u4e0b\u75c7\u3001\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u3001\u305d\u306e\u4ed6\u306e\u75be\u60a3\u304c\u542b\u307e\u308c\u307e\u3059\u3002<br \/>\n2.  \u6295\u4e0e\u7d4c\u8def\u5225: \u7d4c\u53e3\u3001\u975e\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def\u306b\u5206\u3051\u3089\u308c\u307e\u3059\u3002<br \/>\n3.  \u85ac\u5264\u30af\u30e9\u30b9\u5225: \u30c1\u30aa\u30a2\u30df\u30c9\u3001\u30a4\u30aa\u30f3\u963b\u5bb3\u5264\u3001\u30db\u30eb\u30e2\u30f3\u653e\u51fa\u963b\u5bb3\u5264\u3001\u305d\u306e\u4ed6\u306e\u85ac\u5264\u30af\u30e9\u30b9\u304c\u5bfe\u8c61\u3067\u3059\u3002<br \/>\n4.  \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225: \u5378\u58f2\u6d41\u901a\u3001\u5c0f\u58f2\u5e97\u3001\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u3092\u901a\u3058\u3066\u306e\u8ca9\u58f2\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n5.  \u5730\u57df\u5225: \u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u305d\u306e\u4ed6\u30e8\u30fc\u30ed\u30c3\u30d1\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u3001\u305d\u306e\u4ed6\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\uff08GCC\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u3001\u305d\u306e\u4ed6\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u3001\u305d\u306e\u4ed6\u5357\u7c73\uff09\u3068\u3044\u3063\u305f\u5e83\u7bc4\u306a\u5730\u7406\u7684\u533a\u5206\u3067\u5e02\u5834\u304c\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u5e02\u5834\u306f\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\u304b\u30892030\u5e74\uff09\u306b\u304a\u3044\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff093.5%\u3067\u7740\u5b9f\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u306a\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u3068\u3057\u3066\u306f\u3001Abbvie Inc.\u3001Merck KGaA\u3001Pfizer Inc.\u3001Exelixis Inc.\u3001Viatris Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5730\u57df\u5225\u306b\u898b\u308b\u3068\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u304a\u308a\u3001\u5927\u304d\u306a\u5e02\u5834\u6a5f\u4f1a\u3092\u79d8\u3081\u3066\u3044\u308b\u3053\u3068\u304c\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u30012025\u5e74\u6642\u70b9\u3067\u306f\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u5f15\u304d\u7d9a\u304d\u91cd\u8981\u306a\u5e02\u5834\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u5e02\u5834\u898f\u6a21\u30c7\u30fc\u30bf\u3068\u30012025\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u5c06\u6765\u4e88\u6e2c\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u306e\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001Abbvie Inc.\u3001Amgen Inc.\u3001GSK Plc\u3001Merck KGaA\u3001Viatris Inc.\u3001Novartis AG\u3001Pfizer Inc.\u3001Takeda Pharmaceutical Company Limited\u3001Elexis Inc.\u3001IBSA Pharma (IBSA Group)\u3068\u3044\u3063\u305f\u4e3b\u8981\u4f01\u696d\u306e\u8a73\u7d30\u306a\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306b\u306f\u3001\u5404\u4f01\u696d\u306e\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u3066\u304a\u308a\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u5404\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u7acb\u3061\u4f4d\u7f6e\u3068\u6226\u7565\u3092\u7406\u89e3\u3059\u308b\u4e0a\u3067\u8cb4\u91cd\u306a\u60c5\u5831\u6e90\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u6700\u5f8c\u306b\u3001\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u3064\u3044\u3066\u3082\u6df1\u304f\u6398\u308a\u4e0b\u3052\u3066\u304a\u308a\u3001\u4eca\u5f8c\u306e\u5e02\u5834\u767a\u5c55\u306e\u65b9\u5411\u6027\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/73310"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=73310"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/73310\/revisions"}],"predecessor-version":[{"id":73313,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/73310\/revisions\/73313"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=73310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=73310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=73310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}